Lorenza Rimassa

Thousands gather in London in march for ‘lasting peace’ in Gaza Director of Palestine Solidarity Campaign says ceasefire agreement says nothing about ‘system of apartheid’ in Palestine • Gaza ceasefire – live updates Thousands of people have gathered in central London to call for “lasting peace” in Gaza, a day after the ceasefire agreement between Israel and Hamas came into effect. The demonstration, organised by the Palestine Solidarity Campaign, began at Victoria Embankment on Saturday. Stalls sold keffiyehs and people handed out placards that read “from the river to the sea, Palestine will be free”, “it’s not a crime to act against genocide” and “Starmer has blood on his hands, free Palestine”. Continue reading...

Thousands gather in London in march for ‘lasting peace’ in Gaza

Diane Keaton, Oscar-winning star of Annie Hall and The Godfather, dies aged 79 The Oscar-winner best known for her many collaborations with Woody Allen, as well as films including Reds, The First Wives Club and The Book Club, has died Diane Keaton, one of the best-loved film stars of the past 50 years, has died at the age of 79 in California. The news was confirmed by People magazine. Further details are not available at this time, and her loved ones have asked for privacy, according to a family spokesperson. Continue reading...

Diane Keaton, Oscar-winning star of Annie Hall and The Godfather, dies aged 79

Already registered for #ESMO25?
Your Virtual Congress Bag is waiting!

📂 Access, view, and download all the essential materials designed to make your congress experience even better.

Get your congress bag today!
🔗 https://ow.ly/XMXL50X96wY

📸 What is your #myESMOStory? Share a group photo and tell us.
Use #myESMOStory, tag ESMO and those who shaped your #ProfessionalPath.
#ESMO25
🔗 ow.ly/SWfE50X8mFJ

📸 Tell us your #myESMOStory with a selfie. Do not forget to tag those who have been part of your journey. #ESMO25 #ONEoncologycommunity
🔗 ow.ly/xsOA50X8nzt

#ESMO25: Do not miss the latest findings in #CancerResearch brought to you by the #ESMOAmbassadors & become part of the conversation in #oncology.
🔗 ow.ly/Tkr850X9A1a

The full ENDURO report has just been published at @LancetGastroHep - www.thelancet.com/journals/lan...

#GastroSky #MedSky #UEGWeek

Opening plenary time at #UEGWeek!

The first research of the session is presented by Yorick van de Pavert, with the ENDURO trial of endoscopic versus surgical gastroenterostomy for palliation of malignant gastric outlet obstruction

#GastroSky #MedSky

Palliative treatment with endoscopic gastroenterostomy was superior to surgical gastroenterostomy for time to resumption of solid oral intake and was non-inferior for the rate of persistent or recurrent obstructive symptoms requiring re-intervention

#GastroSky #MedSky #UEGWeek

La scandalosa nomina dei due medici idoli dei no-vax nel comitato per le politiche vaccinali - Valigia Blu Il governo italiano ha nominato nel comitato tecnico consultivo per le politiche vaccinali due figure controverse: Paolo Bellavite ed Eugenio Serravalle, noti per le loro posizioni critiche sull’obbli...

💈 La scandalosa nomina dei due medici idoli dei no-vax nel comitato per le politiche vaccinali
www.valigiablu.it/schillaci-no...

3 Out of 5 Liver Cancer Cases Are Preventable, Study Finds

Proud and honored to be part of @thelancet.com Commission on #livercancer #HCC.
3 Out of 5 Liver Cancer Cases Are Preventable, Study Finds www.nytimes.com/2025/07/28/w...

The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment Liver cancer is the sixth most common cancer and the third leading cause of cancer-related mortality globally. The number of new liver cancers will nearly double, from 0·87 million in 2022 to 1·52 mil...

The global burden of #livercancer is increasing. 📈
#HCC accounts for approx. 80% of cases globally.
💡 Proud and honored to be part of the new Commission which outlines evidence-based recommendations for action to reduce the global HCC burden: www.thelancet.com/journals/lan...
@thelancet.com

Dr. Dario Trapani - Global Oncology: Yvonne Awards 2025 Dr. Dario Trapani is an Italian-born medical oncologist, global cancer policy expert, and academic. He currently serves as Assistant Professor

Dr. Dario Trapani – Global Oncology: Yvonne Awards 2025

oncodaily.com/insight/dr-d...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Promotional card for The Lancet Commission on hepatocellular carcinoma. Background image depicts a computer-generated illustration of a human torso with an inflamed liver.

The global burden of liver cancer is increasing. 📈

Hepatocellular carcinoma (HCC) accounts for approximately 80% of cases globally.

💡 A new Commission outlines evidence-based recommendations for action to reduce the global HCC burden: tinyurl.com/yzxvktkw

Incredibly proud to be part of @thelancet.com Commission on #HCC

How we treat patients with advanced #BTC #CCA from #ESMOGI25. Expert centers, MDTs, molecular profiling, chemo-immunotherapy, and targeted agents @vjoncology.bsky.social

Expert-led Post-#ASCO2025 & #ESMOGI2025 Highlights webinars 💻📍

The #GICancer session will be chaired by
@lorenzarimassa.bsky.social & moderated by Richard Kim, Filippo Pietrantonio & Efrat Dotan

AGENDA 👉 buff.ly/NtN20KG

REGISTER 👉 buff.ly/4Z7VyTB

Glad to chair the @vjoncology.bsky.social webinar on #GI cancer and discuss the most important data presented at #ASCO and #ESMOGI with experts in the field!
Please see below the agenda and join us!

Welcome!👋

We are a global, open access, expert-led video journal bringing healthcare professionals trustworthy, cutting-edge news in #Oncology🔦

🏥Disease areas www.vjoncology.com/subjects/#all

🎧VJOncology Podcast www.vjoncology.com/podcasts/

📩VJOncology Newsletter www.vjoncology.com/newsletter/

Glad to chair the @vjoncology.bsky.social webinar on #GI cancer and discuss the most important data presented at #ASCO and #ESMOGI with experts in the field!
Please see below the agenda and join us!

Lorenza Rimassa: New Survival Benchmark for People Living with Advanced Biliary Tract Cancer - OncoDaily Lorenza Rimassa: New Survival Benchmark for People Living with Advanced Biliary Tract Cancer / Aiwu Ruth He, Aleksandra Kuzko, Arndt Vogel, Biliary tract

New Survival Benchmark for People Living with Advanced Biliary Tract Cancer - Lorenza Rimassa
@lorenzarimassa.bsky.social

oncodaily.com/science/lore...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GIOnc #BiliaryTractCancer

Longitudinal study sets new survival benchmark for patients with advanced biliary tract cancer In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an immunotherapy drug) plus gemcitabine and cisplatin (GemCis, chemotherapy drugs) as the...

Longitudinal study sets new survival benchmark for patients with advanced biliary tract cancer | EurekAlert! www.eurekalert.org/news-release...

25 Posts Not To Miss From ESMO GI 2025 - OncoDaily The ESMO Gastrointestinal Cancers Congress (ESMO GI 2025) took place in Barcelona, Spain, from from July 2 to July 5, uniting global oncology professionals committed to improving outcomes across the s...

25 Posts Not To Miss From ESMO GI 2025
@myesmo.bsky.social
@lorenzarimassa.bsky.social
@arndtvogel.bsky.social
@ermanakkus.bsky.social
@rachnatshroff.bsky.social

oncodaily.com/societies/25...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOGI25 #ESMO #GIOnc

#TeresaMacarulla nicely summarizes new data on #HPB cancers presented at #ESMOGI2025 #HCC #BTC #CCA #PDAC #ESMOAmbassadors @myesmo.bsky.social Post n.2

#TeresaMacarulla nicely summarizes new data on #HPB cancers presented at #ESMOGI2025 #HCC #BTC #CCA #PDAC #ESMOAmbassadors @myesmo.bsky.social

@myesmo.bsky.social updated guidelines and living guidelines on #GI cancers presented by #MichelDucreux at #ESMOGI2025 #ESMOAmbassadors

Patient’s perspective presented by #ZoranaMaravic @digestivecancerseu.bsky.social at #ESMOGI2025 #ESMOAmbassadors @myesmo.bsky.social

Promising results of olaparib as a potential new #PrecisionOncology treatment for patients with biliary tract cancer #BTC #CCA and aberrant #HRR mutations. #ESMOGI25 #ESMOAmbassadors @myesmo.bsky.social

Prof Tabernero lecture on lessons learned from #GI translational research and the path forward at #ESMOGI25 @myesmo.bsky.social #ESMOAmbassadors